ImmunoGen Inc (IMGN) Stock Analyst Ratings
NASDAQ:IMGN • US45253H1014
31.23 USD
0 (0%)
At close: Feb 9, 2024
31.24 USD
+0.01 (+0.03%)
After Hours: 2/9/2024, 8:00:02 PM
ChartMill assigns a Buy % Consensus number of 71% to IMGN. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 31.69. This target is 1.46% above the current price.
- IMGN was analyzed by 19 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about IMGN.
- In the previous month the buy percentage consensus was at a similar level.
- IMGN was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-04 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2023-12-04 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2023-12-01 | Guggenheim | Downgrade | Buy -> Neutral |
| 2023-12-01 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2023-12-01 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2023-12-01 | Jefferies | Downgrade | Buy -> Hold |
| 2023-11-30 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-11-20 | Goldman Sachs | Initiate | Neutral |
| 2023-11-09 | Deutsche Bank | Initiate | Buy |
| 2023-11-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-06 | Oppenheimer | Initiate | Perform |
| 2023-09-13 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2023-08-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-02 | Barclays | Maintains | Overweight -> Overweight |
| 2023-08-01 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-08-01 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-08-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-12 | Barclays | Maintains | Overweight |
| 2023-06-12 | Canaccord Genuity | Reiterate | Buy -> Buy |
| 2023-06-06 | Truist Securities | Maintains | Buy -> Buy |
| 2023-06-05 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-05-03 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2023-05-01 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-02 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-23 | JP Morgan | Maintains | Neutral |
| 2022-12-30 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-21 | Truist Securities | Initiate | Buy |
| 2022-11-16 | BMO Capital | Maintains | Outperform |
| 2022-11-16 | Canaccord Genuity | Maintains | Buy |
ImmunoGen Inc / IMGN FAQ
What do analysts expect the price target to be for ImmunoGen Inc (IMGN)?
19 analysts have analysed IMGN and the average price target is 31.69 USD. This implies a price increase of 1.46% is expected in the next year compared to the current price of 31.23.
What is the consensus rating for ImmunoGen Inc (IMGN) stock?
The consensus rating for ImmunoGen Inc (IMGN) is 70.5263 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for ImmunoGen Inc stock?
The number of analysts covering ImmunoGen Inc (IMGN) is 19.